Markus Bulgrin

Markus Bulgrin is an experienced communications professional with a robust background in public relations and corporate communications. Currently serving as Director of Communications at Astellas Pharma since July 2023, Markus previously held the position of Director of Public Relations at CureVac from May 2022 to July 2023. Prior roles include Head of Corporate Communications & PR at Engelhard Arzneimittel and Head of External Communications/Senior Manager Media & International PR at Heraeus. With experience at NORMA Group as Senior Manager Group Communications and a background in journalism as an Online Editor at Frankfurter Rundschau, Markus also worked in various editorial roles at Frankfurter Rundschau and Financial Times Deutschland. Markus holds a Master of Arts degree in Germanistik und Literatur from Goethe University Frankfurt.